01—History
EPS (Diluted) History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2021–FY2026. Drag across the bars to change the range.
- $10.43
02—Ledger
EPS (Diluted), period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2026 | $10.43 | +9.7% | 10-K | |
| FY2025 | $9.51 | +37.4% | 10-K | |
| FY2024 | $6.92 | +13.6% | 10-K | |
| FY2023 | $6.09 | +14.9% | 10-K | |
| FY2022 | $5.30 | +63.6% | 10-K | |
| FY2021 | $3.24 | −24.1% | 10-K | |
| FY2020 | $4.27 | +52.5% | 10-K | |
| FY2019 | $2.80 | +27.9% | 10-K | |
| FY2018 | $2.19 | −8.8% | 10-K | |
| FY2017 | $2.40 | −3.6% | 10-K | |
| FY2016 | $2.49 | +0.8% | 10-K | |
| FY2015 | $2.47 | +3.3% | 10-K | |
| FY2014 | $2.39 | +13.8% | 10-K | |
| FY2013 | $2.10 | +22.8% | 10-K | |
| FY2012 | $1.71 | +18.8% | 10-K | |
| FY2011 | $1.44 | +17.1% | 10-K | |
| FY2010 | $1.23 | +29.5% | 10-K | |
| FY2009 | $0.95 | — | 10-K |
03—Questions
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is ResMed's current eps (diluted)?
ResMed (RMD) annual eps (diluted) for 2026 was $10.43, a 9.67% increase from 2025. ResMed eps (diluted) for the quarter ending September 30, 2026 was $2.92.
What was ResMed's eps (diluted) in 2025?
ResMed annual eps (diluted) for 2025 was $9.51, a 37.43% increase from 2024.
What was ResMed's eps (diluted) in 2024?
ResMed annual eps (diluted) for 2024 was $6.92, a 13.63% increase from 2023.
What is ResMed's 5-year eps (diluted) CAGR?
ResMed eps (diluted) grew at a compound annual growth rate (CAGR) of 26.34% from FY2021 to FY2026, going from $3.24 to $10.43 over 5 years.
- Company
- ResMed
- Ticker
- RMD
- Sector
- Healthcare
- Industry
- Surgical & Medical Instruments & Apparatus